Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasia

By Santisteban Marta  

Breast Cancer Research and Treatment, Vol. 121, Iss. 2, 2010-06 ,pp. : 431-437

Springer Publishing Company

Access to resources Recommend Favorite

Clinical and histopathological factors associated with Ki-67 expression in breast cancer patients

By  

Oncology Letters, Vol. 9, Iss. 3, 2015-01 ,pp. : 1046-1054

Spandidos Publications

Access to resources Recommend Favorite

Ki67 as a predictor of poor prognosis in patients with triplenegative breast cancer

By  

Oncology Letters, Vol. 9, Iss. 1, 2015-01 ,pp. : 149-152

Spandidos Publications

Access to resources Recommend Favorite

Ki67 is a promising molecular target in the diagnosis of cancer (Review)

By  

Molecular Medicine Reports, Vol. 11, Iss. 3, 2015-01 ,pp. : 1566-1572

Spandidos Publications

Access to resources Recommend Favorite

Studies of the Potential Utility of Ki67 as a Predictive Molecular Marker of Clinical Response in Primary Breast Cancer

By Assersohn L.  

Breast Cancer Research and Treatment, Vol. 82, Iss. 2, 2003-01 ,pp. : 113-123

Springer Publishing Company

Access to resources Recommend Favorite